This IF THEN gate integrating CD19-SynNotchand PDbody-CAR should enhance the specificity of T cell killing andpotentially minimize on-target off-tumor toxicity in adoptive celltherapy, as PDbody-CAR is induced and maintained mainly in the proximityof “training centers” where SynNotch engages the CD19antigen. Here, CD19 is linked to neoplasm.